Boehringer Ingelheim Academy
Find out more about our networking and educational initiative
Search
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Mutual benefit: Patient-centricity in clinical trials
Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Our Partners Bioharmony
Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.
Partnering_In_CENTRALNERVOUS_0
Partnering_In_Imm_0422
Partnering_In_ORALHEALTH_0
Partnering_In_PAIN_0
Partnering_In_TECHNOLOGIES_0
Partnering_In_DIGITAL_SCIENCE_0
Partnering_In_PARASITOLOGY_0
20210823_Your_Guide_to_Partnering_with_Us
Partnering_In_INFECTIOUS_1
Partnering_In_Oncology_0422
Partnering_In_CARDIOMETABOLIC_0
Pets
Pets
Equiphoria helping stroke patients hippotherapy
To further research, we're partnering with Equiphoria, a French therapy center for hippotherapy.
Our Partners_ViraTherapeutics
Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Meet our Team
Meet our Team
Therapeutics
Therapeutics
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Clinical Collaborations
Clinical Collaborations
Research Collaborations
Research Collaborations
Our Health and Safety initiative - BE SAFE
Health and safety are of great importance to Boehringer Ingelheim.